caplyta.com — August 2026 traffic, keywords & AI visibility

Search engines send caplyta.com an estimated 36,000 visits a month. Effectively all of it is organic — about 36,000 visits from unpaid results. Paid search contributes only about 19 visits a month. Spread across 682 ranking keywords, that averages roughly 53 organic visits per keyword.

caplyta.com scores 67 out of 100 on our AI visibility scale, grade C. It takes full marks for LLMS.txt and Structured data. The biggest gap is SEO health, at 0 of 20 points (0/100), worth 20 points if closed. It also loses points on Crawlability (0/10) and Company profile (22/25).

The llms.txt on caplyta.com runs to 75 lines (3,864 characters) across 12 sections, last generated in May 2026. It introduces the site as "Caplyta Official Site". It tells AI engines the business works in Healthcare, Pharmaceuticals and Mental Health. It describes 1 product, including Caplyta (lumateperone). Services it lists include Patient Support Program, Doctor Discussion Guide and Medication Guide. The audience it names is Patients diagnosed with schizophrenia or bipolar depression, aged Adults 18+ (United States). Technologies it mentions include viewport and https. The keywords it claims start with "schizophrenia", "bipolar depression", "lumateperone" and "mental health".

# Caplyta Official Site

## About
Caplyta is a once-daily prescription medication indicated for adults with schizophrenia and bipolar depression. The treatment is designed to help manage symptoms and support daily functioning. The official website provides prescribing information, a medication guide, and resources for cost savings. Patients can download discussion guides to prepare for conversations with their healthcare providers. The site also features condition-specific pages that explain how Caplyta works for schizophrenia and bipolar depression. Educational content focuses on safety, dosing, and what to expect during treatment. Cost-savings programs are highlighted to help reduce out-of-pocket expenses for eligible patients. The brand works with psychiatrists and primary-care physicians to improve access and awareness. Caplyta is distributed through standard pharmacy channels across the United States. The website serves as the primary source for both patients and healthcare professionals seeking reliable information. Ongoing clinical research continues to explore long-term outcomes and potential additional uses. The company maintains a straightforward digital presence that prioritizes safety information and patient support. Caplyta’s messaging emphasizes working closely with qualified healthcare providers. Resources are written in clear language to help users make informed

Google lists caplyta.com for about 682 keywords, which together bring an estimated 36,000 organic visits a month.

The latest technical audit of caplyta.com scored 0 out of 100 overall. The audit makes 8 recommendations in all.

Caplyta's company profile names https://www.jnjlabels.com, https://www.mentalhealth.gov, https://www.nami.org and https://www.mayoclinic.org as competitors. Its own llms.txt adds webmd.com and healthline.com. Outside its market, the domains ranked closest to it in our worldwide ranking are hosterserver.com, northwood.edu, uzumtezkor.uz and canarywharf.com.

https://www.jnjlabels.com

https://www.mentalhealth.gov

https://www.nami.org

https://www.mayoclinic.org

webmd.com

healthline.com